Anti-Human IL17RA Recombinant Antibody (Ixekizumab) (CAT#: TAB-217)

Recombinant monoclonal antibody to IL17RA. Ixekizumab is a humanized monoclonal antibody used in the treatment of autoimmune diseases.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Tested Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
SDS-PAGE

Figure 1 Anti-Human IL17RA Recombinant Antibody (TAB-217) in SDS-PAGE

Figure 1 Anti-Human IL17RA Recombinant Antibody (TAB-217) in SDS-PAGE

SDS-PAGE analysis of TAB-217 in non-reduced (Lane 1, 2.5ug) and reduced (Lane 2, 2.5ug) conditions.


Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • undefined
  • Derivation
  • Humanized
  • Type
  • IgG4 - kappa
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in WB, IP, IF, FuncS, FC, Neut, ELISA and most other immunological methods.
  • CAS
  • 1143503-69-8
  • Generic Name
  • Ixekizumab
  • MW
  • 146.2 kDa
  • Related Disease
  • Psoriasis

Product Property

  • Purity
  • Purity >95% by SDS-PAGE.
  • Storage
  • Store at -20°C. Avoid multiple freeze/thaw cycles.

Target

  • Alternative Names
  • Ixekizumab;1143503-69-8;LY2439821;IL17RA;interleukin 17 receptor A;IL17R, interleukin 17 receptor;interleukin-17 receptor A;CD217;CDw217;hIL 17R;IL 17RA;IL-17 receptor A;IL17R;CANDF5;IL-17RA;hIL-17R;FLJ32274;FLJ36453;MGC10262;

Related Resources

  • Biosimilar Overview
Please refer to Ixekizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Ixekizumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Ixekizumab"

Afuco™ Anti-IL17RA ADCC Recombinant Antibody (Ixekizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL17RA. Ixekizumab is a humanized monoclonal antibody used in the treatment of autoimmune diseases.

See other products for "IL17RA"

Single-domain Antibody

CAT Product Name Application Type
NABL-093 Recombinant Anti-human IL17RA VHH Single Domain Antibody WB, ELISA, IHC, FC, FuncS Llama VHH

Human Antibody

CAT Product Name Application Type
TAB-134 Human Anti-IL17RA Recombinant Antibody (TAB-134) Neut, ELISA, IF, IP, FuncS, FC, ICC Human IgG2, κ

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-1794 Rabbit Anti-IL17RA Recombinant Antibody (clone DS1794AB) WB, IP, FC Rabbit IgG

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-134 Afuco™ Anti-IL17RA Recombinant Antibody (AFC-TAB-134), ADCC Enhanced Neut, ELISA, IF, IP, FuncS, FC Human IgG1, κ
AFC-TAB-217 Afuco™ Anti-IL17RA ADCC Recombinant Antibody (Ixekizumab), ADCC Enhanced ELISA, FC, IP, FuncS, IF ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-217. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare